Penn Medicine - Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania

Public research footprint of Penn Medicine - Perelman Center for Advanced Medicine, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed B-Cell Non-Hodgkin Lymphoma · Refractory B-Cell Non-Hodgkin Lymphoma · Cutaneous Squamous Cell Carcinoma (CSCC) · Fibrodysplasia Ossificans Progressiva (FOP)

Recently updated registry entries

NCT04970901 — A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in… (Active Not Recruiting)
NCT06585410 — Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous… (Recruiting)
NCT06377852 — The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Penn Medicine - Perelman Center for Advanced Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.